JP2002515858A5 - - Google Patents

Download PDF

Info

Publication number
JP2002515858A5
JP2002515858A5 JP1997519125A JP51912597A JP2002515858A5 JP 2002515858 A5 JP2002515858 A5 JP 2002515858A5 JP 1997519125 A JP1997519125 A JP 1997519125A JP 51912597 A JP51912597 A JP 51912597A JP 2002515858 A5 JP2002515858 A5 JP 2002515858A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997519125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515858A (ja
Filing date
Publication date
Priority claimed from US08/557,287 external-priority patent/US5686414A/en
Application filed filed Critical
Publication of JP2002515858A publication Critical patent/JP2002515858A/ja
Publication of JP2002515858A5 publication Critical patent/JP2002515858A5/ja
Ceased legal-status Critical Current

Links

JP51912597A 1995-11-14 1996-11-12 角膜移植に起因する疾患を処置するための殺菌/浸透性増強(bpi)タンパク質 Ceased JP2002515858A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/557,287 US5686414A (en) 1995-11-14 1995-11-14 Methods of treating conditions associated with corneal transplantation
US08/557,287 1995-11-14
PCT/US1996/018416 WO1997017989A1 (en) 1995-11-14 1996-11-12 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation

Publications (2)

Publication Number Publication Date
JP2002515858A JP2002515858A (ja) 2002-05-28
JP2002515858A5 true JP2002515858A5 (enExample) 2004-10-28

Family

ID=24224798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51912597A Ceased JP2002515858A (ja) 1995-11-14 1996-11-12 角膜移植に起因する疾患を処置するための殺菌/浸透性増強(bpi)タンパク質

Country Status (6)

Country Link
US (1) US5686414A (enExample)
EP (1) EP0861087A1 (enExample)
JP (1) JP2002515858A (enExample)
AU (1) AU730303B2 (enExample)
CA (1) CA2235625C (enExample)
WO (1) WO1997017989A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
CA2235626C (en) * 1995-11-14 2002-01-01 Xoma Corporation Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
IL156427A0 (en) * 2000-12-19 2004-01-04 Res Dev Foundation Lentiviral vector-mediated gene transfer and uses thereof
SE523017C2 (sv) 2001-03-30 2004-03-23 Aga Ab Publ Spolfluidkomposition
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
ZA200703708B (en) * 2004-11-08 2008-09-25 Unilever Plc Liquid detergent composition
FR2882930B1 (fr) * 2005-03-09 2009-03-27 Walid Katib Nouvelles compositions ophtalmologiques et leur mode d'utilisation
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US9585745B2 (en) 2010-06-21 2017-03-07 James Stuart Cumming Foldable intraocular lens with rigid haptics
US9351825B2 (en) 2013-12-30 2016-05-31 James Stuart Cumming Semi-flexible posteriorly vaulted acrylic intraocular lens for the treatment of presbyopia
US9918830B2 (en) 2010-06-21 2018-03-20 James Stuart Cumming Foldable intraocular lens with rigid haptics
US9295545B2 (en) 2012-06-05 2016-03-29 James Stuart Cumming Intraocular lens
US8523942B2 (en) 2011-05-17 2013-09-03 James Stuart Cumming Variable focus intraocular lens
US9295544B2 (en) 2012-06-05 2016-03-29 James Stuart Cumming Intraocular lens
US10736732B2 (en) 2010-06-21 2020-08-11 James Stuart Cumming Intraocular lens with longitudinally rigid plate haptic
US9295546B2 (en) 2013-09-24 2016-03-29 James Stuart Cumming Anterior capsule deflector ridge
CA2858173C (en) 2011-12-06 2023-09-26 Advanced Cell Technology, Inc. Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof
US20140155871A1 (en) * 2012-05-10 2014-06-05 James Stuart Cumming Method for preparing corneal donor tissue for refractive eye surgery utilizing the femtosecond laser
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
US9615916B2 (en) 2013-12-30 2017-04-11 James Stuart Cumming Intraocular lens
JP2024519218A (ja) 2021-05-03 2024-05-09 アステラス インスティテュート フォー リジェネレイティブ メディシン 成熟角膜内皮細胞を作製する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
EP0682524B1 (en) * 1993-02-02 2001-10-04 XOMA Technology Ltd. Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US5348942A (en) * 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
CA2235626C (en) * 1995-11-14 2002-01-01 Xoma Corporation Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury

Similar Documents

Publication Publication Date Title
JP2000502578A5 (enExample)
JP2000500228A5 (enExample)
JP2000500445A5 (enExample)
JP2000500440A5 (enExample)
JP2000502864A5 (enExample)
JP2000500327A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2000500406A5 (enExample)
JP2000500361A5 (enExample)
JP2000500115A5 (enExample)
JP2000500322A5 (enExample)
JP2000500258A5 (enExample)
JPH11512021A5 (enExample)
JP2000500342A5 (enExample)
JP2000500192A5 (enExample)
JPH11510414A5 (enExample)
JP2000500112A5 (enExample)
JP2000500226A5 (enExample)
JP2000500397A5 (enExample)
JP2000500407A5 (enExample)
JP2000500166A5 (enExample)
JP2002515858A5 (enExample)
JPH11509055A5 (enExample)
JP2000500125A5 (enExample)